Send mail to Author

Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2a and ribavirin in a large noninterventional cohort study (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   __    _____    _____      _____     ______    _____   
 \ \\/ //  |  ___|| |  __ \\   |  ___||  /_   _//  |  ___|| 
  \   //   | ||__   | |  \ ||  | ||__    `-| |,-   | ||__   
  / . \\   | ||__   | |__/ ||  | ||__      | ||    | ||__   
 /_//\_\\  |_____|| |_____//   |_____||    |_||    |_____|| 
 `-`  --`  `-----`   -----`    `-----`     `-`'    `-----`
 


Back to frontdoor view

OPUS4 Logo